Robin A. E. Carr

4.7k citations

26 papers · 2.3k indexed · 2 hit papers · h-index 16

Computational Theory and Mathematics top 1%
- Computational Drug Discovery Methods 3
Molecular Biology top 5%
- Chemical Synthesis and Analysis 9
- Genomics, phytochemicals, and oxidative stress 2
Organic Chemistry top 5%
- Click Chemistry and Applications 3
- Asymmetric Synthesis and Catalysis 3
Toxicology top 5%
- Bioactive Compounds and Antitumor Agents 2
Biochemistry top 5%
Spectroscopy
- Analytical Chemistry and Chromatography 5
Biomedical Engineering
- Innovative Microfluidic and Catalytic Techniques Innovation 3

Co-authors: Miles Congreve Christopher W. Murray Harren Jhoti David C. Rees Dominic Tisi Rob L. M. van Montfort Thomas G. Davies Anne Cleasby
Cited by: Computational Theory and Mathematics Molecular Biology Organic Chemistry
Journals: Tetrahedron Letters (4 papers)Journal of Medicinal Chemistry (4 papers)The Journal of Organic Chemistry (3 papers)
Partner nations: United Kingdom United States China

In The Last Decade

Robin A. E. Carr

25 papers receiving 2.2k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Robin A. E. Carr

Since Specialization

Citations

This map shows the geographic impact of Robin A. E. Carr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robin A. E. Carr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robin A. E. Carr more than expected).

Fields of papers citing papers by Robin A. E. Carr

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robin A. E. Carr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robin A. E. Carr. The network helps show where Robin A. E. Carr may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Robin A. E. Carr, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Robin A. E. Carr Line = papers co-authored together Robin A. E. Carr links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	MYC deregulation sensitizes cancer cells to N-myristoyltransferase inhibition Cell Reports ·冨雄小田,James Zhang,Monica Faronato,陈刚,Wouter W. Kallemeijn,Francesco Falciani,Josephine Walton,Gurpreet K. Sidhu,Samuele Vannini,Evon Poon,Barbara Martins Da Costa,Roberto Solari,Robin A. E. Carr,Andrew Bell,Edward Bartlett,施勇峰,Martin Janz,Louis Chesler,Dinis Pedro Calado,Edward W. Tate	2025	0
2	Abstract 2635: N-Myristolytransferase (NMT) inhibitors as novel potent payloads for antibody drug conjugates Cancer Research ·Robin A. E. Carr,Roberto Solari,H. Wang,Sema Çıtak,Josephine Walton,M. G. Matvienko	2023	2
3	Structure of the BTB Domain of Keap1 and Its Interaction with the Triterpenoid Antagonist CDDO PLoS ONE ·Anne Cleasby,Jeff Yon,Philip J. Day,Caroline J. Richardson,Ian J. Tickle,Pamela A. Williams,James F. Callahan,Robin A. E. Carr,N.O. Concha,Jeffrey K. Kerns,Hongwei Qi,Thomas D. Sweitzer,Paris Ward,Thomas G. Davies	2014	202
4	Identification of Inhibitors of Protein Kinase B Using Fragment-Based Lead Discovery Journal of Medicinal Chemistry ·Gordon Saxty,Steven J. Woodhead,Valério Berdini,Thomas G. Davies,Marcel L. Verdonk,Paul G. Wyatt,Robert G. Boyle,David Barford,Robert Downham,Michelle D. Garrett,Robin A. E. Carr	2007	110
5	Application of Fragment Screening by X-ray Crystallography to the Discovery of Aminopyridines as Inhibitors of β-Secretase Journal of Medicinal Chemistry ·Miles Congreve,David Aharony,Jeffrey S. Albert,Owen Callaghan,James B. Campbell,Robin A. E. Carr,Gianni Chessari,Faisal Akbar Saenal,Philip D. Edwards,Martyn Frederickson,Rachel McMenamin,Christopher W. Murray,Sahil Patel,Nicola G. Wallis	2007	107
6	Fragment-based lead discovery: leads by design Drug Discovery Today ·Robin A. E. Carr,Miles Congreve,Christopher W. Murray,David C. Rees	2005	246
7	Fragment-based lead discoverybreakdown → Nature Reviews Drug Discovery ·David C. Rees,Miles Congreve,Christopher W. Murray,Robin A. E. Carr	2004	567
8	Identification of Novel p38α MAP Kinase Inhibitors Using Fragment-Based Lead Generation Journal of Medicinal Chemistry ·Adrian L. Gill,Martyn Frederickson,Anne Cleasby,Steven J. Woodhead,Maria G. Carr,Andrew Woodhead,Andreas Greiner,Miles Congreve,Lindsay A. Devine,Dominic Tisi,Marc O’Reilly,Lisa C. A. Seavers,Deborah Davis,Jayne Curry,C Darsow,Alessandro Padova,Christopher W. Murray,Robin A. E. Carr,Harren Jhoti	2004	146
9	Oxidation state of the active-site cysteine in protein tyrosine phosphatase 1Bbreakdown → Nature ·Rob L. M. van Montfort,Miles Congreve,Dominic Tisi,Robin A. E. Carr,Harren Jhoti	2003	521
10	Structure-based screening of low-affinity compounds Drug Discovery Today ·Robin A. E. Carr,Harren Jhoti	2002	75
11	Reporter Resins for Solid-Phase Chemistry Organic Letters ·Miles Congreve,Mark Ladlow,Peter S. Marshall,Nigel J. Parr,Jan Scicinski,Tom D. Sheppard,A. V. Murugova,Robin A. E. Carr	2001	7
12	A photolabile carbamate based dual linker analytical construct for facile monitoring of solid phase chemistry: ‘TLC’ for solid phase? Tetrahedron Letters ·Stephen C. McKeown,Steve P. Watson,Robin A. E. Carr,Peter S. Marshall	1999	37
13	Enolate bromination in 2-acyl-1,3-dithiane 1-oxides Tetrahedron ·Philip C. Bulman Page,Michael J. McKenzie,Steven M. Allin,E. W. COLLINGTON,Robin A. E. Carr	1995	5
14	The maximum degree in a random tree and related problems Random Structures and Algorithms ·Robin A. E. Carr,William M. Y. Goh,Pross Mugimba	1994	4
15	Diastereoselective electrophilic amination of ketone enolates in 2-substituted 2-acyl-1,3-dithiane 1-oxides Tetrahedron Letters ·Philip C. Bulman Page,Steven M. Allin,E. W. COLLINGTON,Robin A. E. Carr	1994	13
16	Enantioselective synthesis of (R)-(−)-2,6-dimethyl heptanoic acid: The first application of the DITOX asymmetric building block Tetrahedron Letters ·Philip C. Bulman Page,Steven M. Allin,E. W. COLLINGTON,Robin A. E. Carr	1994	16
17	High diastereofacial selectivity in asymmetric Mannich reaction of acyldithiane oxide enolates The Journal of Organic Chemistry ·Philip C. Bulman Page,Steven M. Allin,E. W. COLLINGTON,Robin A. E. Carr	1993	30
18	Synthesis and reactions of derivatives of 1,7-dioxaspiro[5.5]undec-2-en-4-one The Journal of Organic Chemistry ·Anthony G. M. Barrett,Robin A. E. Carr,Thu Nguyen Thi Hong,Jean‐Claude Florent,Mar Bornay-Barrachina,N. D. A. WALSHE	1986	18
19	Total synthesis of (+)-milbemycin .beta.3 The Journal of Organic Chemistry ·Anthony G. M. Barrett,Robin A. E. Carr,Atheer H Herez,Mar Bornay-Barrachina,N. D. A. WALSHE	1986	71
20	ChemInform Abstract: Total Synthesis of (+)‐Milbemycin B3. Chemischer Informationsdienst ·Atheer H Herez,Anthony G. M. Barrett,Robin A. E. Carr,Mar Bornay-Barrachina	1986	2

About Robin A. E. Carr

Robin A. E. Carr is a scholar working on Toxicology, Organic Chemistry and Spectroscopy, having authored 26 papers that have together received 2.3k indexed citations. Recurring topics across this work include Chemical Synthesis and Analysis (9 papers), Analytical Chemistry and Chromatography (5 papers), Innovative Microfluidic and Catalytic Techniques Innovation (3 papers), Click Chemistry and Applications (3 papers), Computational Drug Discovery Methods (3 papers), Asymmetric Synthesis and Catalysis (3 papers), Genomics, phytochemicals, and oxidative stress (2 papers) and Bioactive Compounds and Antitumor Agents (2 papers). The work is most often cited by research in Computational Theory and Mathematics (594 citations), Molecular Biology (1.7k citations) and Organic Chemistry (624 citations). Robin A. E. Carr has collaborated with scholars based in United Kingdom, United States and China. Frequent co-authors include Miles Congreve, Christopher W. Murray, Harren Jhoti, David C. Rees, Dominic Tisi, Rob L. M. van Montfort, David C. Rees, Thomas G. Davies, Anne Cleasby and Anthony G. M. Barrett. Their work appears in journals such as Tetrahedron Letters, Journal of Medicinal Chemistry, The Journal of Organic Chemistry, Drug Discovery Today and Random Structures and Algorithms.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact